...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: https://scr.zacks.co...

A major Zenith Epi partnership with a major BP will 100% help RVX right after that  as the expectation that if one pharma is interested other will want into the epigenetics tech that don't already have a footprint in the tech 

 

 

Share
New Message
Please login to post a reply